RECURRENCE AND MORTALITY OF CHRONIC SUBDURAL HEMATOMA: EXPERIENCE OF TWO CENTERS IN A MIDDLE-INCOME COUNTRY

Autores/as

  • Francisco Valderrama-Arias Department of Neurological Surgery, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia
  • juan m torres Department of Neurological Surgery, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia
  • Nadin Abdala Vargas Department of Neurological Surgery, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia.
  • Gabriela Morales-Guarín Schoolof Medicine, Fundación Universitaria de Ciencias de la Salud (FUCS) Bogotá, Colombia
  • Oscar Zorro-Guio Department of Neurological Surgery, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia
  • Hernando Cifuentes-Lobelo Department of Neurological Surgery, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia.
  • William Cortes-Lozano Department of Neurological Surgery, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia.
  • Jorge Arana-Carvahlo Department of Neurological Surgery, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia
  • Javier patiño-gomez Department of Neurological Surgery, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia
  • edgar ordoñez-mora Department of Neurological Surgery, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital de San José, Bogotá, Colombia
  • Edgar Gerardo Ordóñez-Rubiano Neurocirujano, Instructor Asistente. Fundación Universitaria de Ciencias de la Salud (FUCS) - Hospital de San José https://orcid.org/0000-0003-1179-5825

DOI:

https://doi.org/10.51437/nj.v28i2.58

Palabras clave:

Chronic Subdural Hematoma, Low-to-middle Income Country, Burr Hole, Craniotomy, Recurrence, Mortality

Resumen

Objective: To determine the prevalence of risk factors for recurrence and mortality among patients who underwent drainage of a chronic subdural hematoma (CSDH) in 2 centers in Colombia in a 3-year period.

Materials and methods: Patients who underwent surgical drainage of a CSDH at the Hospital de San José and at the Hospital Infantil Universitario San José in Bogota, Colombia from January 2016 to January 2019 were included. An analytic cross-sectional study was conducted. Demographic, clinical, and radiological features were collected.

Results: 165 patients were enrolled in the study. 50 (30.3%) were female. The mean patient age was 71 years (61-80). 90 (54.5%) had associated history of trauma. A total of 123 (74.5%) patients underwent surgical intervention with burr holes and 42 (25.5) underwent drainage through a mini-craniotomy. 17 (10.3%) patients suffered a recurrence that required one reoperation. Only 9 (5.5%) had a fatal outcome. None of the variables were significant predictors for recurrence, while the use of oral anticoagulant therapy (OAT) (p = 0.001), the history of traumatic brain injury (TBI) (p =0.047) and the heterogeneous density of the hematoma (p = 0.018) were significant predictors for mortality, respectively.

Conclusions: The use of OAT, the history of TBI, and the heterogeneous density of the hematoma in the CT scan were found to be significant predictors for mortality, while none of the analyzed variables were statistically significant predictors for recurrence in patients who underwent surgical evacuation of a CSDH in our institutions.

Citas

1. Kitya D, Punchak M, Abdelgadir J, Obiga O, Harborne D, Haglund MM. Causes, clinical presentation, management, and outcomes of chronic subdural hematoma at Mbarara Regional Referral Hospital. Neurosurg Focus. 2018;45(4):E7.
2. Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N. Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo). 1992;32(4):207-209.
3. Mezue WC, Ohaebgulam SC, Chikani MC, Erechukwu AU. Changing trends in chronic subdural haematoma in Nigeria. Afr J Med Med Sci. 2011;40(4):373-376.
4. Adhiyaman V, Asghar M, Ganeshram KN, Bhowmick BK. Chronic subdural haematoma in the elderly. Postgrad Med J. 2002;78(916):71-75.
5. Holl DC, Volovici V, Dirven CMF, et al. Corticosteroid treatment compared with surgery in chronic subdural hematoma: a systematic review and meta-analysis. Acta Neurochir (Wien). 2019;161(6):1231-1242.
6. Bansal H, Mahajan A, Singh A, Chaudhary A. Spontaneous Disappearance of a Large Chronic Subdural Hematoma: A Pleasant Surprise. Indian J Surg. 2015;77(6):532-534.
7. Kageyama H, Toyooka T, Tsuzuki N, Oka K. Nonsurgical treatment of chronic subdural hematoma with tranexamic acid. J Neurosurg. 2013;119(2):332-337.
8. Link TW, Boddu S, Paine SM, Kamel H, Knopman J. Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Series of 60 Cases. Neurosurgery. 2018.
9. Liu LX, Cao XD, Ren YM, Zhou LX, Yang CH. Risk Factors for Recurrence of Chronic Subdural Hematoma: A Single Center Experience. World Neurosurg. 2019.
10. Weigel R, Schmiedek P, Krauss JK. Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry. 2003;74(7):937-943.
11. Kolias AG, Chari A, Santarius T, Hutchinson PJ. Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol. 2014;10(10):570-578.
12. Mellergard P, Wisten O. Operations and re-operations for chronic subdural haematomas during a 25-year period in a well defined population. Acta Neurochir (Wien). 1996;138(6):708-713.
13. Traynelis VC. Chronic subdural hematoma in the elderly. Clin Geriatr Med. 1991;7(3):583-598.
14. Bin Zahid A, Balser D, Thomas R, Mahan MY, Hubbard ME, Samadani U. Increase in brain atrophy after subdural hematoma to rates greater than associated with dementia. J Neurosurg. 2018;129(6):1579-1587.
15. Dakurah TK, Iddrissu M, Wepeba G, Nuamah I. Chronic subdural haematoma: review of 96 cases attending the Korle Bu Teaching Hospital, Accra. West Afr J Med. 2005;24(4):283-286.
16. Akbar A. Myelography in spinal disorders--experience of 1400 cases. J Pak Med Assoc. 2004;54(12):604-609.
17. Park BE. Surgical Treatment of Degenerative Lumbar Spine Disease in Rural Sub-Saharan Africa: A Retrospective Study of 450 Cases and Its Future Implications. World Neurosurg. 2016;87:417-421.
18. Ordonez-Rubiano EG, Valderrama-Arias FA, Forbes JA, et al. Identification of Preoperative Language Tracts for Intrinsic Frontotemporal Diseases: A Pilot Reconstruction Algorithm in a Middle-Income Country. World Neurosurg. 2019;125:e729-e742.
19. Chater Cure G, González Martínez D, Peña Quiñones G, Diez Palma J, Jiménez Hakim E, Hakim F. Hematomas Subdurales Crónicos Tratados En El Hospital Universitario Fundación Santa Fe De Bogotá. Neurociencias en Colombia. 2010;17(4):65-81.
20. Moreno Huertas C, Riveros M, Cortes W, Aguilera P. Factores Asociados a Recurrencia en Hematomas Subdurales Crónicos. Un Estudio de Cohorte Retrospectiva en el Hospital Universitario Mayor. Repository. Universidad del Rosario. 2019.
21. Servadei F, Rossini Z, Nicolosi F, Morselli C, Park KB. The Role of Neurosurgery in Countries with Limited Facilities: Facts and Challenges. World Neurosurg. 2018;112:315-321.

Descargas

Publicado

2022-02-08

Cómo citar

Valderrama-Arias, F., Torres, J. M., Abdala-Vargas, N. J., Morales-Guarín, G., Zorro-Guío , O. F., Cifuentes-Lobelo, H. A. ., Cortes-Lozano, W., Arana-Carvahlo , J., Patiño Gómez , J. G., Ordóñez-Mora , E. G., & Ordóñez-Rubiano, E. G. (2022). RECURRENCE AND MORTALITY OF CHRONIC SUBDURAL HEMATOMA: EXPERIENCE OF TWO CENTERS IN A MIDDLE-INCOME COUNTRY. Neurociencias Journal, 28(2), 56–71. https://doi.org/10.51437/nj.v28i2.58

Número

Vol. 28 Núm. 2 (2021): Neurociencias Journal

Sección

Artículo de investigación